Allan Mark Watson

Optos Plc manufactures and markets retinal imaging devices. Its products include ultra-widefield imaging, visual acuity, perimetry, and laser treatment products. The company was founded by Douglas Crombie Anderson in 1992 and is headquartered in Dunfermline, the United Kingdom.

Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.

Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom.

Archimedes Pharma UK Ltd. involves in marketing niche pharmaceutical products. The company is headquartered in London, the United Kingdom.

Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the private company is based in London, UK.

Founded in 1989, Kyowa Kirin Services Ltd. is a subsidiary of Kirin Holdings Co., Ltd. that researches and develops drugs. The private company is based in London, UK.

Part of Kirin Holdings Co., Ltd., Kyowa Kirin GmbH is a German company that manufactures and supplies pharmaceutical products. The company is based in Dusseldorf, Germany. The private company was founded in 2011. The CEO is Norberto Villarrasa Justicia.

Part of Kelso Pharma Ltd., Stirling Anglian Pharmaceuticals Ltd. was founded in 2013 and is a medicines optimization company based in Glasgow, UK. The British company is committed to medicines optimization and has sourced and developed a portfolio of medicines to help the NHS curb waste across a range of conditions that currently place unnecessary and avoidable strain on the healthcare system. Stirling Anglian Pharmaceuticals was acquired by Kelso Pharma Ltd. on January 12, 2022.

Kelso Pharma Ltd. manufactures pharmaceuticals. The company is based in London, UK. and has subsidiaries in United Kingdom. The British company was founded in 2020. The CEO is Harry Thomas Stratford.